The Nifty futures contract traded on the Singapore Exchange shows that local stocks are off to a good start. The contract was worth 17,475.50 at the time of writing, up 120.50 points or 0.69% from the previous close.
Adani Green Energy
The company’s fourth wind-solar hybrid power plant, with a generating capacity of 700 MW, is now fully operational in Jaisalmer, Rajasthan, bringing the company’s total active renewable portfolio to 8,024 MW. The new hybrid plant has a 25-year power purchase agreement (PPA) at Rs 3.24 per kWh. Simultaneously, SB Adani Family Trust sold 5.56 crore of equity shares in Adani Green Energy in open market transactions for Rs 2,805.6 crore at an average price of Rs 504.6 per share. However, the Goldman Sachs Trust II—Goldman Sachs GQG Partners International Opportunities Fund purchased over 2.25 crore equity shares in the company, while the GQG Partners Emerging Markets Equity Fund purchased 1.38 crore shares at an average price of Rs 504.6 per share, totaling Rs 1,833.6 crore.
Mahindra and Mahindra Financial Services
The company thought that it would give out a total of about Rs 4,185 crore in February 2023, which is a 53% increase from February 2022.The loan book increased by 1.5% in February 2023 compared to January 2023.
Happiest Minds Technologies
The company’s board of directors has authorised a Rs 125 crore fundraising through the private placement of 12,500 non-convertible debentures in the domestic market in three tranches.
Hindustan Petroleum Corporation
On a private placement basis, the business raised Rs 1,650 crore via non-convertible taxable debentures.
Karnataka State Bank
Muralidhar Krishna Rao resigned as CFO of Karnataka Bank on March 1, and the bank has hired Abhishek Sankar Bagchi as the new CFO.
SBI and YES Bank
According to Reuters, the State Bank of India may seek to reduce its ownership in Yes Bank once a lock-in period imposed by the central bank as part of the lender’s reorganisation expires on March 13.
Leading multiplex chain operator PVR plans to invest around Rs 450–500 crore in new screens, and the firm, after its merger with Inox, now plans to add 200 screens each year and exploit the potential of smaller regions.
Zydus Lifesciences, Inc.
The United States Food and Drug Administration (USFDA) has granted final clearance to Zydus Lifesciences for Acyclovir Cream, which belongs to the antiviral medicine class.